Country: Bandaríkin
Tungumál: enska
Heimild: NLM (National Library of Medicine)
METHYLPREDNISOLONE SODIUM SUCCINATE (UNII: LEC9GKY20K) (METHYLPREDNISOLONE - UNII:X4W7ZR7023)
AuroMedics Pharma LLC
METHYLPREDNISOLONE SODIUM SUCCINATE
METHYLPREDNISOLONE 40 mg
INTRAMUSCULAR
PRESCRIPTION DRUG
When oral therapy is not feasible, and the strength, dosage form, and route of administration of the drug reasonably lend the preparation to the treatment of the condition, the intravenous or intramuscular use of methylprednisolone sodium succinate for injection is indicated as follows: Allergic states Control of severe or incapacitating allergic conditions intractable to adequate trials of conventional treatment in asthma, atopic dermatitis, contact dermatitis, drug hypersensitivity reactions, serum sickness, transfusion reactions. Dermatologic diseases Bullous dermatitis herpetiformis, exfoliative erythroderma, mycosis fungoides, pemphigus, severe erythema multiforme (Stevens-Johnson syndrome). Endocrine disorders Primary or secondary adrenocortical insufficiency (hydrocortisone or cortisone is the drug of choice; synthetic analogs may be used in conjunction with mineralocorticoids where applicable; in infancy, mineralocorticoid supplementation is of particular importance), congenital adrenal hyperplasia, h
Methylprednisolone sodium succinate for injection, USP is a sterile, white color lyophilized cake, supplied as follows: 40 mg per vial Single-Dose Vials in a Carton of 25 NDC 55150-262-03 125 mg per vial Single-Dose Vials in a Carton of 25 NDC 55150-263-03 500 mg per vial Multiple-Dose Vials Packaged Individually NDC 55150-264-20 2 grams per vial Single-Dose Vials Packaged Individually NDC 55150-265-50 STORAGE CONDITIONS Protect from light. Store unreconstituted product at 20° to 25°C (68° to 77°F) [see USP Controlled Room Temperature]. Store solution at 20° to 25°C (68° to 77°F) [see USP Controlled Room Temperature]. Use solution within 48 hours after mixing. The vial stoppers are not made with natural rubber latex. This product’s label may have been updated. For current full prescribing information, please visit www.auromedics.com . Distributed by: AuroMedics Pharma LLC 279 Princeton-Hightstown Rd. E. Windsor, NJ 08520 Manufactured by: Aurobindo Pharma Limited Hyderabad - 500038 India Revised: July 2021
Abbreviated New Drug Application
METHYLPREDNISOLONE SODIUM SUCCINATE - METHYLPREDNISOLONE SODIUM SUCCINATE INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION AUROMEDICS PHARMA LLC ---------- METHYLPREDNISOLONE SODIUM SUCCINATE FOR INJECTION, USP RX ONLY THE FORMULATIONS CONTAINING BENZYL ALCOHOL SHOULD NOT BE USED IN NEONATES. FOR INTRAVENOUS OR INTRAMUSCULAR ADMINISTRATION DESCRIPTION Methylprednisolone sodium succinate for injection, USP is an anti-inflammatory glucocorticoid, which contains methylprednisolone sodium succinate as the active ingredient. Methylprednisolone sodium succinate USP, is the sodium succinate ester of methylprednisolone, and it occurs as a white, or nearly white, odorless hygroscopic, amorphous solid. It is very soluble in water and in alcohol; it is insoluble in chloroform and is very slightly soluble in acetone. Methylprednisolone sodium succinate USP is the sodium salt of methylprednisolone hemisuccinate USP, which is formed _in situ,_ with the aid of sodium hydroxide. The chemical name for methylprednisolone sodium succinate is pregna-1,4-diene-3,20- dione,21-(3-carboxy-1-oxopropoxy)-11,17-dihydroxy-6-methyl-monosodium salt, (6α, 11β), and the molecular weight is 496.53. The structural formula is represented below: Methylprednisolone sodium succinate USP is soluble in water; it may be administered in a small volume of diluent and is well suited for intravenous use in situations where high blood levels of methylprednisolone are required rapidly. Methylprednisolone sodium succinate for injection, USP is a sterile, white color lyophilized cake, available in preservative and preservative-free formulations: 40 MG (SINGLE-DOSE VIAL): Each mL (when mixed with 1 mL of Water for Injection USP) contains 53 mg of methylprednisolone sodium succinate USP equivalent to 40 mg methylprednisolone; also 1.6 mg monobasic sodium phosphate anhydrous; 17.46 mg dibasic sodium phosphate dried; 25 mg lactose hydrous. This package does not contain diluent. Each mL (when mixed with 1 mL of Bacteriostatic Water for Injection USP) contains 53 mg of Lestu allt skjalið